Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9546673rdf:typepubmed:Citationlld:pubmed
pubmed-article:9546673lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C1145667lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C0483249lld:lifeskim
pubmed-article:9546673lifeskim:mentionsumls-concept:C0599013lld:lifeskim
pubmed-article:9546673pubmed:issue3lld:pubmed
pubmed-article:9546673pubmed:dateCreated1998-5-13lld:pubmed
pubmed-article:9546673pubmed:abstractTextA high-affinity RNA aptamer to human activated protein C (APC) was selected from a pool of random sequences using in vitro selection. Activated protein C, a trypsin-like serine protease plays an important role along with thrombin as a regulator in blood clotting cascade. After seven rounds of selection and amplification, a single predominant nucleic acid sequence APC-167, a 167-base oligonucleotide with a random sequence core of 120 bases, was obtained. The selected aptamer did not bind to thrombin or factor Xa and thus demonstrated specificity to APC. Furthermore, this aptamer was a non-competitive inhibitor to the cleavage reaction of a fluorogenic substrate catalyzed by APC. The inhibition constant (Ki) of APC-167 was 83 nM. The 99-base oligonucleotide (APC-99) derived from APC-167 by deleting both primer binding sites, was also found to inhibit APC strongly (Ki = 137 nM). Two stem-loop structures and at least one G x U wobble base pair in the stem were elucidated as important structural motifs for binding.lld:pubmed
pubmed-article:9546673pubmed:languageenglld:pubmed
pubmed-article:9546673pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9546673pubmed:citationSubsetIMlld:pubmed
pubmed-article:9546673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9546673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9546673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9546673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9546673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9546673pubmed:statusMEDLINElld:pubmed
pubmed-article:9546673pubmed:monthMarlld:pubmed
pubmed-article:9546673pubmed:issn0014-2956lld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:NishikawaSSlld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:NishikawaFFlld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:GayS TSTlld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:KumarP KPKlld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:Vishnuvardhan...lld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:AmontovSSlld:pubmed
pubmed-article:9546673pubmed:authorpubmed-author:UrvilP TPTlld:pubmed
pubmed-article:9546673pubmed:issnTypePrintlld:pubmed
pubmed-article:9546673pubmed:day15lld:pubmed
pubmed-article:9546673pubmed:volume252lld:pubmed
pubmed-article:9546673pubmed:ownerNLMlld:pubmed
pubmed-article:9546673pubmed:authorsCompleteYlld:pubmed
pubmed-article:9546673pubmed:pagination553-62lld:pubmed
pubmed-article:9546673pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:meshHeadingpubmed-meshheading:9546673-...lld:pubmed
pubmed-article:9546673pubmed:year1998lld:pubmed
pubmed-article:9546673pubmed:articleTitleSelection of a RNA aptamer that binds to human activated protein C and inhibits its protease function.lld:pubmed
pubmed-article:9546673pubmed:affiliationNational Institute of Bioscience and Human Technology, AIST, MITI, Tsukuba Science City, Ibaraki, Japan.lld:pubmed
pubmed-article:9546673pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9546673pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9546673lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9546673lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9546673lld:pubmed